Purpose/Objectives: To evaluate the relevance of a five-dimensional model of clinical trial nursing practice in an oncology clinical trial nurse population. 
 Design: Web-based cross-sectional survey.
 Setting: Online via Qualtrics.
 Sample: 167 oncology nurses throughout the United States,...

Purpose/Objectives: To describe oncology nurses’ experiences discussing clinical trials with their patients, and to assess barriers to these discussions.
 Research Approach: A qualitative study designed to elicit narratives from oncology nurses. 
 Setting: Community- and academic-based oncology...

Background: Patients in phase 1 clinical trials often have significant symptom burdens and quality-of-life concerns that increase as they progress along the cancer trajectory and experience drug toxicities from the clinical trial. 
 Objectives: The interdisciplinary intervention described is aimed...

Background: Chimeric antigen receptor (CAR) T-cell therapy is a cellular immunotherapy that redirects the killing activity of T cells to fight tumor cells. CD19 CAR T-cell therapies have demonstrated high rates of complete response in clinical trials in patients with relapsed or refractory B-cell...